Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
- PMID: 31783982
- PMCID: PMC6891229
- DOI: 10.1016/j.vaccine.2019.05.030
Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
Keywords: Adverse event; Amnionitis; Case definition; Chorioamnionitis; Guidelines; Immunization; Intra-amniotic infection.
Conflict of interest statement
Nicola Klein reports research support from GlaxoSmithKline, Pfizer, Sanofi Pasteur, Merck & Co and Protein Science (now Sanofi Pasteur). Kevin Ault is on several data and safety committees for maternal immunization and drug treatment trials.
Figures
References
-
- Ogunyemi D., Murillo M., Jackson U., Hunter N., Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13(2):102–109. - PubMed
-
- Gibbs R.S., Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol. 1991;164(5 Pt 1):1317–1326. - PubMed
-
- Soper D.E., Mayhall C.G., Dalton H.P. Risk factors for intraamniotic infection: a prospective epidemiologic study. Am J Obstet Gynecol. 1989;161(3):562–566. discussion 6–8. - PubMed
